Costs associated with angiogenesis inhibitor therapies for metastatic renal cell carcinoma in clinical practice: results from a medical chart review study.
Choueiri
Toni K
TK
Dana-Farber Cancer Institute, Boston, MA 02115, USA. Toni_Choueiri@dfci.harvard.edu
McDermott
David
D
Sheng Duh
Mei
M
Sarda
Sujata P
SP
Neary
Maureen P
MP
Oh
William K
WK